UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2) is a non-catalytic member of the ubiquitin-conjugating enzyme family that plays critical roles in DNA damage response (DDR), immune signaling, and cancer progression. Unlike canonical E2 enzymes, UBE2V2 lacks the conserved catalytic cysteine required for ubiquitin-thioester formation but partners with UBE2N to synthesize non-canonical Lys-63 (K63)-linked polyubiquitin chains, which regulate cellular signaling rather than proteasomal degradation .
Primary Structure: UBE2V2 is a 145-amino-acid protein (17 kDa) with homology to yeast Mms2 and human UBE2V1 .
Key Domains: Contains a ubiquitin-conjugating (UBC) domain but lacks the catalytic cysteine residue (Cys-87 in UBE2N) .
Conserved Cysteine (C69): Serves as a redox sensor, binding reactive electrophilic species (RES) like 4-hydroxynonenal (HNE) to activate downstream signaling .
UBE2V2’s C69 residue exhibits high reactivity toward electrophiles (e.g., HNE), enabling it to function as a redox sensor under oxidative stress . This modification allosterically activates UBE2N, enhancing K63-linked ubiquitination of substrates like PCNA and histones (e.g., H2AX) .
Catalytic Role: The UBE2V2-UBE2N complex assembles K63 chains critical for DDR and NF-κB signaling .
Regulation: UBE2V2 binding increases UBE2N’s enzymatic efficiency by 5–10 fold in vitro .
Expression: UBE2V2 mRNA and protein levels are elevated in LUAD tissues compared to normal controls .
Correlations:
UBE2V2’s dual roles in redox sensing and ubiquitin signaling make it a promising target for:
MGSSHHHHHH SSGLVPRGSH MAVSTGVKVP RNFRLLEELE EGQKGVGDGT VSWGLEDDED MTLTRWTGMI IGPPRTNYEN RIYSLKVECG PKYPEAPPSV RFVTKINMNG INNSSGMVDA RSIPVLAKWQ NSYSIKVVLQ ELRRLMMSKE NMKLPQPPEG QTYNN.
UBE2V2, also known as the human homologue of yeast MMS2, is a catalytically inactive protein that forms a functional complex with UBE2N (Ubc13). Despite lacking enzymatic activity itself, UBE2V2 is crucial for the ubiquitination pathway as it works with UBE2N to synthesize Lys63-linked ubiquitin chains . These chains can either be unanchored or attached to target proteins, playing significant roles in facilitating responses to various forms of DNA damage . UBE2V2 contains one conserved cysteine residue (C69) that has been identified as a privileged sensor for reactive electrophilic species, establishing it as a bridge between redox signaling and ubiquitin-dependent pathways .
The UBE2N/UBE2V2 complex functions with ubiquitin ligases (E3s), including RNF111 and RNF8, to coordinate protein modification through ubiquitination . This process is fundamental to cellular processes including DNA damage repair, signal transduction, and protein quality control.
Human UBE2V2 is a 17 kDa protein containing a single cysteine residue (C69) . When forming a complex with UBE2N (18 kDa), the functional unit contains distinct domains that facilitate ubiquitin transfer. The specific structural features include:
A highly conserved cysteine (C69) that is present from humans to yeast
An N-terminal region that facilitates complex formation with UBE2N
A ubiquitin-conjugating enzyme variant (UEV) fold that structurally resembles E2 enzymes but lacks catalytic activity
When expressed recombinantly with an N-terminal His-tag, the protein maintains its ability to form functional complexes with UBE2N and participate in ubiquitination reactions .
Alignments of UBE2V2 across vertebrate species show remarkable conservation, particularly of the C69 residue, which is preserved from humans to yeast . This high degree of evolutionary conservation suggests that UBE2V2 serves a fundamental cellular function that has been maintained throughout eukaryotic evolution.
The conserved nature of UBE2V2 and its homologues is particularly evident in comparison with related proteins:
Human UBE2V2 (Mms2) and UBE2V1 (Uev1) share homologous structures
The analogous cysteine residue (C69 in UBE2V2 and C94 in UBE2V1) is conserved across species
Saccharomyces cerevisiae and Schizosaccharomyces pombe homologues (Ubc6) maintain similar structural features
This conservation underscores the protein's essential role in cellular processes, particularly in DNA damage response pathways that are fundamental to genomic integrity across eukaryotic organisms.
The UBE2V2/UBE2N interaction represents a fascinating example of functional complementation where a catalytically inactive protein (UBE2V2) enhances the activity of an enzymatically active partner (UBE2N). The complex formation occurs through specific protein-protein interfaces that position both proteins for optimal ubiquitin transfer .
When forming a complex with UBE2N, UBE2V2 contributes to:
Specific recognition of ubiquitin molecules for Lys63-linked chain formation
Proper orientation of the acceptor ubiquitin for chain extension
Enhanced interaction with E3 ubiquitin ligases like RNF111 and RNF8
The recombinant human His6-UBE2N/UBE2V2 complex is typically formulated at 0.88 mg/ml (25 μM) in 50 mM HEPES pH 7.5, 200 mM NaCl, 10% Glycerol (v/v), and 2 mM TCEP . This formulation maintains the stability of the complex and preserves its activity for in vitro applications. For experimental ubiquitination reactions, an initial concentration of 0.1-1 μM of the complex is typically recommended .
The C69 residue in UBE2V2 has emerged as a critical sensor for reactive electrophilic species (RES) such as 4-hydroxynonenal (HNE) . This finding, identified through the "G-REX" technique, represents a novel function for UBE2V2 beyond its role in ubiquitination:
C69 demonstrates kinetic privilege in detecting electrophiles under physiological conditions
This cysteine is conserved from humans to yeast, suggesting evolutionary importance
Modification of C69 by electrophiles like HNE leads to allosteric activation of the UBE2N partner enzyme
This activation promotes enhanced K63-linked ubiquitination and stimulates H2AX-dependent DNA damage response
Notably, the HNE-sensing ability of UBE2V2 (with one cysteine) surpasses that of UBE2V1 (with three cysteines), demonstrating that electrophile sensitivity is not simply correlated with cysteine content but depends on the specific biochemical environment around the reactive residue . The significance of this site was verified through multiple approaches, including:
G-REX proteome-wide identification
Targeted T-REX modification in live cells
This redox-sensing capability positions UBE2V2 as a "Rosetta stone" bridging redox signaling and ubiquitin-dependent pathways in the maintenance of genome integrity .
For optimal use of recombinant UBE2N/UBE2V2 complex in ubiquitination assays, researchers should consider several factors that affect reaction efficiency and specificity:
Recommended reaction conditions:
Buffer system: 50 mM HEPES pH 7.5 with 200 mM NaCl
Reducing agent: 2 mM TCEP to maintain cysteine residues in reduced state
Temperature: Typically 30-37°C for human protein interactions
E1 enzyme: Required for initial ubiquitin activation
E3 ligase: Appropriate E3 (e.g., RNF111, RNF8) should be included for substrate specificity
ATP and Mg²⁺: Essential cofactors for the ubiquitination cascade
When working with carrier-free preparations, special attention should be paid to protein stability, as the absence of carrier proteins like BSA can affect shelf-life and activity . For applications where the presence of carrier proteins might interfere, such as certain mass spectrometry analyses or specific enzymatic assays, the carrier-free version is preferred .
Reaction parameters will need optimization for each specific experimental system, particularly when investigating novel substrates or E3 ligase combinations.
Several complementary approaches have proven effective for investigating UBE2V2 function in cellular systems:
1. CRISPR/Cas9-mediated knockout cell lines:
The UBE2V2 knockout in HCT 116 colorectal cancer cells represents a valuable tool for studying the consequences of UBE2V2 ablation . These cells allow researchers to:
Investigate altered protein turnover in cancer cells
Unveil mechanisms contributing to tumor progression
Study resistance to therapies in the absence of UBE2V2-dependent ubiquitination
2. Site-specific modification approaches:
The G-REX and T-REX platforms enable controlled release of reactive electrophiles in vivo, allowing researchers to:
Target specific cysteines for modification under physiological conditions
Identify first-responding innate cysteines that bind electrophiles
Verify site-specific modifications through mass spectrometry analysis
3. Functional ubiquitination assays:
Monitoring K63-linked ubiquitination in cellular contexts can be achieved through:
Immunoprecipitation of target proteins followed by ubiquitin chain-specific antibody detection
Monitoring DNA damage response markers like H2AX phosphorylation
Analyzing protein complex formation through co-immunoprecipitation studies
These methodologies provide complementary insights into UBE2V2 function, from biochemical mechanisms to cellular consequences of UBE2V2 activity or its absence.
UBE2V2 plays a critical role in DNA damage response (DDR) through its ability to form K63-linked ubiquitin chains in conjunction with UBE2N . The contribution of UBE2V2 to DDR includes:
Formation of K63-linked ubiquitin chains on histone H2AX and other chromatin-associated proteins
Recruitment of DNA repair factors to sites of damage
Enabling specific signaling cascades required for various DNA repair mechanisms
The UBE2N/UBE2V2 complex works with E3 ligases like RNF8 to facilitate these responses to DNA damage . Additionally, the electrophile-sensing capability of UBE2V2 through its C69 residue represents an intriguing mechanism by which oxidative stress (which often accompanies DNA damage) can trigger enhanced DDR signaling .
This dual functionality - both as a component of the ubiquitination machinery and as a redox sensor - positions UBE2V2 as a central coordinator that integrates different cellular stress response pathways to maintain genome integrity.
UBE2V2 knockout cell lines, particularly in cancer models like HCT 116 colorectal cancer cells, have emerged as valuable tools for investigating the role of ubiquitination in cancer biology . The implications of UBE2V2 knockout include:
1. Understanding ubiquitin signaling in cancer:
Altered protein turnover in the absence of UBE2V2-dependent K63 ubiquitination
Uncovering mechanisms contributing to tumor progression that rely on UBE2V2 function
Evaluating resistance to therapies linked to ubiquitin-dependent pathways
2. Drug development applications:
Screening novel anti-cancer compounds in a UBE2V2-deficient background
Identifying synthetic lethal interactions with UBE2V2 deficiency
Developing targeted strategies based on ubiquitination pathway dependencies
3. Mechanistic studies:
Dissecting the role of ubiquitin-conjugating enzymes in cancer progression
Evaluation of DNA damage response efficiency in the absence of UBE2V2
Understanding compensatory mechanisms that may emerge in UBE2V2-deficient cells
These knockout models facilitate significant enhancements in the accuracy of cancer mechanistic studies and therapeutic evaluations, potentially leading to improved outcomes in developing targeted cancer treatments .
UBE2V2 serves as a functional bridge between redox and ubiquitin signaling pathways, earning its description as a "Rosetta Stone" linking these two crucial cellular regulatory systems . This integrative function is facilitated by several key mechanisms:
Electrophile sensing through C69: The conserved C69 residue acts as a privileged sensor for reactive electrophilic species (RES) like 4-hydroxynonenal (HNE), which are products of oxidative stress
Allosteric activation of UBE2N: When C69 is modified by electrophiles, UBE2V2 undergoes conformational changes that allosterically hyperactivate its binding partner UBE2N, despite UBE2N itself not being directly modified
Enhanced ubiquitination activity: This activation promotes increased K63-linked ubiquitination of client proteins, particularly those involved in DNA damage response
Functional specificity: Despite structural similarities between UBE2V1 and UBE2V2, electrophile modification triggers responses specific to each protein, highlighting the precise nature of this signaling mechanism
The linkage between these pathways is particularly significant because it provides a direct mechanistic connection between oxidative stress (which generates electrophilic species) and the ubiquitin-dependent pathways that regulate critical cellular processes like DNA repair. This mechanism enables cells to respond to oxidative damage not only through direct antioxidant defenses but also by enhancing DNA repair capacity through ubiquitin-dependent signaling.
The chemoselectivity of ubiquitination reactions involving UBE2V2 depends on several factors that collectively determine the specificity and efficiency of ubiquitin transfer:
Complex formation: The precise structural arrangement of the UBE2N/UBE2V2 complex creates a specific binding interface that determines interaction specificity with both ubiquitin and E3 ligases
Active site architecture: Although UBE2V2 itself lacks catalytic activity, subtle rearrangements in the active site region of the complex influence preferential activity toward specific substrates
E3 ligase cooperation: The UBE2N/UBE2V2 complex works with specific E3 ligases like RNF111 and RNF8, which contribute additional layers of substrate specificity
Lysine specificity: The UBE2N/UBE2V2 complex specifically synthesizes K63-linked ubiquitin chains, distinguishing it from other E2 enzymes that might generate different linkage types
Redox modification effects: Modification of UBE2V2's C69 residue by electrophiles can alter the activity and potentially the specificity of the complex, providing an additional regulatory mechanism
These determinants collectively ensure that ubiquitination reactions involving UBE2V2 proceed with appropriate specificity, targeting the correct substrates with the proper ubiquitin chain types needed for specific cellular functions, particularly in DNA damage response pathways.
Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2) is a crucial component of the ubiquitin-proteasome system (UPS), which is responsible for the regulation of protein degradation in eukaryotic cells. This enzyme plays a significant role in various cellular processes, including DNA repair, cell cycle regulation, and signal transduction.
UBE2V2, also known as UEV2, is a member of the E2 ubiquitin-conjugating enzyme family. Unlike other E2 enzymes, UBE2V2 does not have ubiquitin ligase activity on its own. Instead, it forms a heterodimer with UBE2N (Ubc13), another E2 enzyme. This heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through lysine 63 (Lys-63). These Lys-63-linked poly-ubiquitin chains do not target proteins for degradation by the proteasome but are involved in signaling pathways, such as DNA damage response and NF-κB activation .
The UBE2V2/UBE2N heterodimer is essential for various cellular functions. It mediates the transcriptional activation of target genes and plays a critical role in the DNA damage response. The formation of Lys-63-linked poly-ubiquitin chains by UBE2V2/UBE2N is crucial for the recruitment of DNA repair proteins to sites of damage, thereby facilitating the repair process .
Mutations or dysregulation of UBE2V2 have been implicated in several diseases, including cancer and neurodegenerative disorders. For instance, alterations in the ubiquitination process can lead to the accumulation of damaged or misfolded proteins, contributing to the pathogenesis of these diseases. Understanding the role of UBE2V2 in these processes can provide insights into potential therapeutic targets for treating such conditions .
Recombinant human UBE2V2 is widely used in research to study its function and interactions with other proteins. By using recombinant proteins, researchers can investigate the molecular mechanisms underlying ubiquitination and its role in various cellular processes. Additionally, recombinant UBE2V2 can be utilized in drug discovery efforts to identify compounds that modulate its activity, offering potential therapeutic benefits .